drugset / Trial / NCT00545103

Prevention of Recurrence of Diverticulitis

NCT00545103

Phase 3 Completed 592 enrolled Shire
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.

Timeline

Start
2007-12-06
Primary completion
2011-11-28
Completion
2011-11-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesalamine Small molecule 1.2 g
Subject Mesalamine Small molecule 2.4 g
Subject Mesalamine Small molecule 4.8 g

Indications